NCT02855892 - A Phase II Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Patients With BPH | Biotech Hunter

Enrollment

161

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions

Benign Prostatic Hyperplasia (BPH)

Interventions

OTHER

Placebo

DRUG

GV1001

Trial Locations (8)

Hanyang University Guri Hospital, Guri-si

Seoul National University Bundang Hospital, Seongnam-si

Dongguk University Gyeongju Hospital, Gyeongju

Inje University Busan Paik Hospital, Busan

Keimyung University Dongsan Medical Center, Daegu

Chung-ang University Hospital, Seoul

Eulji General Hospital, Seoul

Severance Hospital, Seoul